{"gene":"SPINK5","run_date":"2026-04-28T20:42:08","timeline":{"discoveries":[{"year":2007,"finding":"LEKTI is produced as a precursor rapidly cleaved by furin, generating multiple single or multidomain fragments (D1, D5, D6, D8-D11, D9-D15) that are secreted in keratinocytes and epidermis. All LEKTI fragments except D1 specifically and differentially inhibit human kallikreins 5, 7, and 14, with the strongest inhibition by D8-D11 toward KLK5 in a rapid, irreversible, tight-binding complex. pH governs this interaction, with acidic pH releasing active KLK5 from the complex, enabling precisely regulated KLK5 activity and corneodesmosomal cleavage in the superficial stratum corneum.","method":"Biochemical analysis with panel of LEKTI antibodies, kinetic analysis of inhibitory activity on serine proteases, pH-dependent interaction assays","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 1 — in vitro kinetic assay with multiple orthogonal methods, strong mechanistic dissection of pH-dependent regulation","pmids":["17596512"],"is_preprint":false},{"year":2003,"finding":"LEKTI is expressed as a 145 kDa full-length protein and a 125 kDa isoform in differentiated keratinocytes; both are N-glycosylated and rapidly processed in a post-endoplasmic reticulum compartment into C-terminal fragments of 42, 65, and 68 kDa by furin. Treatment with a furin inhibitor blocked processing, and in vitro cleavage of recombinant 145 kDa precursor by furin generated the 65 and 68 kDa C-terminal fragments directly.","method":"Monoclonal/polyclonal antibody detection, furin inhibitor treatment of keratinocytes, in vitro cleavage assay with recombinant furin, conditioned media analysis","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro cleavage plus cell-based inhibitor experiments with multiple orthogonal methods","pmids":["12915442"],"is_preprint":false},{"year":2002,"finding":"Loss-of-function SPINK5 mutations cause markedly elevated trypsin-like hydrolytic activity in stratum corneum of Netherton syndrome patients, supporting the model that SPINK5-derived LEKTI peptides normally inhibit serine proteases to regulate corneocyte desquamation.","method":"SPINK5 mutation characterization, enzymatic activity assay of trypsin-like hydrolytic activity in stratum corneum from NS patients vs. controls","journal":"The Journal of investigative dermatology","confidence":"Medium","confidence_rationale":"Tier 2 — loss-of-function with specific biochemical readout, single lab","pmids":["11874482"],"is_preprint":false},{"year":2005,"finding":"LEKTI and its kallikrein targets KLK5 and KLK7 are all localized within lamellar granules of normal epidermis but are separately stored; LEKTI is secreted earlier than KLK7 and KLK5, preventing premature loss of stratum corneum integrity. In Netherton syndrome skin lacking LEKTI, an abnormal split in the superficial stratum granulosum is observed.","method":"Confocal laser scanning microscopy and immunoelectron microscopy of human epidermis; comparison with NS patient skin","journal":"The Journal of investigative dermatology","confidence":"High","confidence_rationale":"Tier 2 — direct subcellular localization by immunoelectron microscopy with functional consequence in disease model, replicated with NS patient tissue","pmids":["15675955"],"is_preprint":false},{"year":2005,"finding":"LEKTI domain 6 is a potent inhibitor of hK5 (KLK5) and hK7 (KLK7) at nanomolar concentrations, while LEKTI domain 15 inhibits plasmin. This identifies KLK5 and KLK7 as specific physiological targets of LEKTI domain 6 relevant to skin desquamation and inflammation.","method":"In vitro inhibitory activity assays of recombinant LEKTI domains 6 and 15 against purified kallikreins hK5 and hK7","journal":"The British journal of dermatology","confidence":"High","confidence_rationale":"Tier 1 — in vitro biochemical assay with purified recombinant proteins, domain-specific functional mapping","pmids":["16307658"],"is_preprint":false},{"year":2005,"finding":"LEKTI fragments containing Kazal domains 6-8 and 9-12 potently inhibit recombinant KLK5 (Ki 1.2–5.5 nM at pH 8.0; 10–20 nM at pH 5.0) with slow dissociation rates (t1/2 ~20–25 min), indicating tight and specific binding. Only fragment 6-9' was a good inhibitor of KLK7 (Ki 11 nM at pH 8.0), with rapidly reversible kinetics. Lower pH reduces inhibitory potency, consistent with a pH-controlled release mechanism.","method":"Recombinant protein expression, kinetic and equilibrium binding studies measuring Ki, kass, and kdis at pH 8.0 and 5.0","journal":"Biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstituted kinetic assay with rigorous quantitation at multiple pH values","pmids":["16307483"],"is_preprint":false},{"year":2003,"finding":"Full-length recombinant LEKTI (rLEKTI) inhibits serine proteinases plasmin, subtilisin A, cathepsin G, human neutrophil elastase, and trypsin via a noncompetitive mechanism (Ki values: 27 nM for plasmin to 849 nM for trypsin), but does not inhibit chymotrypsin or cysteine proteinases. Disulfide bonds are required for inhibitory activity.","method":"Baculovirus/insect cell recombinant expression, kinetic inhibition assays, DTT inactivation experiments","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstituted assay with multiple substrates and mechanism determination","pmids":["12667078"],"is_preprint":false},{"year":2006,"finding":"The magnitude of serine protease (KLK5, KLK7) activation in the stratum corneum correlates with permeability barrier defect severity and clinical severity in Netherton syndrome, and inversely with residual LEKTI expression. LEKTI co-localizes with KLK5 and KLK7 in the stratum corneum and inhibits both. Excess serine protease activity in NS leads to proteolysis of lipid hydrolases (beta-glucocerebrosidase, acidic sphingomyelinase), disorganization of lamellar membranes, and degradation of corneodesmosomes via DSG1/DSC1 cleavage, with compensatory upregulation of DSG3/DSC3.","method":"Patient phenotype correlation with SP activity assays, LEKTI immunolocalization, lamellar membrane analysis by electron microscopy, desmoglein/desmocollin western blotting","journal":"The Journal of investigative dermatology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods in patient tissue establishing mechanistic pathway from LEKTI loss to barrier phenotype","pmids":["16601670"],"is_preprint":false},{"year":2007,"finding":"LEKTI domain specificity for inhibiting SC protease activities was mapped: domains 6-12 predominantly inhibit trypsin-like (Phe-Ser-Arg-) activity; domains 12-15 inhibit plasmin- and trypsin-like (Pro-Phe-Arg-) activities; all domains inhibit chymotrypsin-like activity; no domains inhibit furin-like activity. KLK levels are significantly elevated in the SC and serum of NS patients, and LEKTI domain length correlates with protease inhibitory activity and clinical severity.","method":"Recombinant LEKTI domain proteins, protease inhibition assays with SC extracts, KLK quantification by immunoassay in NS patients","journal":"The Journal of investigative dermatology","confidence":"High","confidence_rationale":"Tier 1-2 — domain-specific inhibitory mapping with recombinant proteins correlated with patient genotype/phenotype","pmids":["17989726"],"is_preprint":false},{"year":2011,"finding":"A proteolytic activation cascade of LEKTI in the epidermis was defined by antibody mapping, N-terminal sequencing, and site-specific mutagenesis, identifying most physiologically generated LEKTI polypeptides and three new processing intermediates. The most effective LEKTI fragments against desquamation-related KLKs were shown to inhibit KLK-mediated proteolysis of desmoglein-1, and fragment ratios relative to active KLK5 in the uppermost epidermis are compatible with fine-tuned inhibitory control.","method":"Antibody mapping, N-terminal sequencing, site-specific mutagenesis, KLK proteolysis assays, fragment quantification in epidermis","journal":"The Journal of investigative dermatology","confidence":"High","confidence_rationale":"Tier 1 — reconstitution with mutagenesis plus mass spectrometric sequencing and quantitative fragment analysis","pmids":["21697885"],"is_preprint":false},{"year":2012,"finding":"The common LEKTI E420K variant (Glu420Lys) increases furin-dependent cleavage within the D6-D7 linker region, reversing cleavage priorities during LEKTI activation and preventing formation of the D6-D9 fragment with the strongest KLK5-inhibitory activity. This results in enhanced KLK5, KLK7, and elastase-2 activities in 420KK epidermis, reduced DSG1 expression, accelerated profilaggrin proteolysis, and increased TSLP expression.","method":"In vitro furin cleavage assays, in situ and gel zymographies, immunohistochemistry, western blot in patient-derived 420KK epidermis","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1-2 — biochemical reconstitution of cleavage plus multiple orthogonal functional readouts in patient tissue","pmids":["22730493"],"is_preprint":false},{"year":2006,"finding":"SPINK5 generates three classes of transcripts by alternative pre-mRNA processing, encoding three LEKTI isoforms differing in their C-terminal portion (15-domain, 13-domain, and a longer isoform with a 30-amino-acid insertion between domains 13 and 14). All isoforms are translated in differentiated keratinocytes and generate distinct secreted C-terminal proteolytic fragments from a similar cleavage site.","method":"RT-PCR, protein expression analysis in differentiated keratinocytes, N-terminal sequencing of secreted fragments","journal":"The Journal of investigative dermatology","confidence":"Medium","confidence_rationale":"Tier 2 — alternative splicing characterization with protein-level validation in keratinocytes","pmids":["16374478"],"is_preprint":false},{"year":2010,"finding":"Lentiviral SPINK5 gene delivery to NS keratinocytes restored LEKTI expression in previously deficient cells. Genetically corrected NS keratinocytes formed normal epidermal architecture in organotypic culture and in vivo mouse/human skin grafts, including a bystander benefit in surrounding uncorrected cells, consistent with LEKTI being a secreted protein.","method":"Lentiviral transduction of NS keratinocytes, organotypic culture, in vivo xenograft engraftment model, immunofluorescence for LEKTI and epidermal markers","journal":"Molecular therapy","confidence":"Medium","confidence_rationale":"Tier 2 — loss-of-function rescue with defined functional and architectural readouts in two model systems","pmids":["20877344"],"is_preprint":false},{"year":2014,"finding":"Keratinocyte-specific mesotrypsin (PRSS3) activates pro-KLK5 and pro-KLK7 in vitro, and degrades LEKTI inhibitory domains (D2, D2-5, D2-6, D2-7, D5, D6, D6-9, D7, D7-9, D10-15) that normally suppress KLK activity—whereas mesotrypsin itself is not inhibited by these LEKTI fragments. Proximity ligation assay demonstrated close association between mesotrypsin and KLKs in granular to cornified layers, placing mesotrypsin upstream of KLK activation and LEKTI degradation in desquamation.","method":"In vitro activation assays of KLK zymogens by mesotrypsin, LEKTI domain inhibition/degradation assays, immunoelectron microscopy, proximity ligation assay in human skin sections","journal":"The Journal of investigative dermatology","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro reconstitution plus in situ proximity ligation providing pathway position for LEKTI regulation","pmids":["24390132"],"is_preprint":false},{"year":2006,"finding":"LEKTI and KLK5, KLK6, and KLK14 are expressed in the pituitary gland. SPINK5 inhibitory domain fragments suppress KLK4, KLK5, and KLK14 activities in vitro. KLKs 4-6, 8, 13, and 14 cleave human growth hormone (hGH) in vitro, generating isoforms, suggesting SPINK5/LEKTI regulates KLK-mediated hGH processing in the pituitary.","method":"RT-PCR and immunohistochemistry for expression in pituitary, in vitro recombinant hGH digestion by KLKs, N-terminal sequencing of fragments, LEKTI fragment inhibition of KLK activities","journal":"Clinica chimica acta","confidence":"Medium","confidence_rationale":"Tier 1 — in vitro reconstitution but in a non-skin tissue context with single lab","pmids":["17140555"],"is_preprint":false},{"year":2019,"finding":"SPINK5 overexpression in esophageal cancer cells inhibits the Wnt/β-catenin signaling pathway by inhibiting GSK3β phosphorylation and promoting β-catenin protein degradation (shown in combination with LiCl or MG-132 treatment). SPINK5 overexpression in vivo significantly inhibits esophageal cancer cell growth. Co-immunoprecipitation confirmed an indirect interaction between SPINK5 (LEKTI) and STAT3.","method":"Western blot for Wnt/β-catenin components, LiCl/MG-132 chemical epistasis, in vivo tumor growth assay, Co-IP for SPINK5-STAT3 interaction","journal":"Cancer medicine","confidence":"Low","confidence_rationale":"Tier 3 — single lab, indirect Co-IP and chemical epistasis without direct enzymatic mechanism established","pmids":["30868765"],"is_preprint":false},{"year":2022,"finding":"miR-5100 targets SPINK5 mRNA (confirmed by luciferase reporter assay), reducing LEKTI expression and thereby activating STAT3 phosphorylation, promoting melanoma cell metastasis via epithelial-mesenchymal transition. Metformin inhibits the miR-5100/SPINK5/STAT3 pathway. Co-IP confirmed an indirect interaction between SPINK5 and STAT3.","method":"Luciferase reporter assay for miR-5100 targeting SPINK5, migration/wound healing assays, Co-IP, in vivo metastasis model in mice","journal":"Cellular & molecular biology letters","confidence":"Medium","confidence_rationale":"Tier 2-3 — luciferase validation of miRNA targeting plus functional assays, but SPINK5-STAT3 mechanism is indirect","pmids":["35705923"],"is_preprint":false},{"year":2019,"finding":"Compound K (CK), an active ginsenoside metabolite, increases SPINK5 gene promoter activity and SPINK5/LEKTI expression in UVB-irradiated keratinocytes, resulting in decreased downstream KLK5, KLK7, and PAR2 expression, and restored epidermal barrier function (transepidermal water loss, hydration) in UVB-irradiated and DNCB-induced atopic dermatitis mouse models.","method":"Transactivation (promoter) assay, RT-PCR, western blot in HaCaT cells, TEWL and hydration measurement, histology in mouse models","journal":"Journal of ginseng research","confidence":"Medium","confidence_rationale":"Tier 2-3 — promoter activity assay with in vivo functional readouts, mechanistic pathway positioned through SPINK5 induction","pmids":["33192123"],"is_preprint":false},{"year":2016,"finding":"In atopic dermatitis lesions, KLK7 secretion from lamellar granules is impaired and LEKTI expression is increased, correlating with retention of corneodesmosomes and compact hyperkeratosis. In situ zymography showed that KLK activity on tape-stripped corneocytes from AD lesions was not significantly elevated despite increased KLK7 protein levels, implicating upregulated LEKTI as a compensatory mechanism suppressing desquamation.","method":"Western blot, immunostaining, electron microscopy, in situ zymography on AD patient tape-stripped corneocytes","journal":"The Journal of investigative dermatology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple methods in patient tissue linking LEKTI upregulation to impaired protease activity and clinical phenotype","pmids":["27769847"],"is_preprint":false}],"current_model":"SPINK5 encodes LEKTI, a multi-domain serine protease inhibitor that is synthesized as a high-molecular-weight precursor in differentiated keratinocytes, cleaved by furin into multiple bioactive fragments stored separately from its targets KLK5 and KLK7 in lamellar granules, secreted into the extracellular space of the stratum granulosum, and there potently inhibits KLK5, KLK7, and KLK14 in a pH-dependent manner—releasing active kallikreins at acidic pH to enable precisely regulated corneodesmosomal proteolysis and desquamation, with loss of LEKTI function causing uncontrolled serine protease activity, barrier breakdown, and Netherton syndrome."},"narrative":{"teleology":[{"year":2002,"claim":"Establishing that SPINK5 loss of function leads to excess serine protease activity in the stratum corneum linked the gene product to direct protease inhibition during desquamation and confirmed its role in Netherton syndrome pathogenesis.","evidence":"Enzymatic activity assays of trypsin-like activity in stratum corneum of NS patients with characterized SPINK5 mutations versus controls","pmids":["11874482"],"confidence":"Medium","gaps":["Single lab, no identification of specific protease targets","Mechanism of inhibition not determined"]},{"year":2003,"claim":"Defining furin as the processing protease and mapping LEKTI precursor cleavage into discrete C-terminal fragments established the biosynthetic pathway from full-length precursor to secreted inhibitory peptides.","evidence":"Furin inhibitor treatment of keratinocytes blocked processing; in vitro cleavage of recombinant 145 kDa precursor by purified furin reconstituted the fragments","pmids":["12915442"],"confidence":"High","gaps":["Exact number and identity of all physiological fragments not yet known","N-terminal fragments not characterized"]},{"year":2003,"claim":"Demonstrating that full-length recombinant LEKTI inhibits multiple serine proteinases (plasmin, subtilisin A, cathepsin G, elastase, trypsin) via a noncompetitive mechanism requiring disulfide bonds established the biochemical class of inhibition.","evidence":"Kinetic inhibition assays with baculovirus-expressed LEKTI against a panel of serine and cysteine proteinases, with DTT inactivation","pmids":["12667078"],"confidence":"High","gaps":["Physiological kallikrein targets (KLK5, KLK7) not yet tested","Domain-specific contributions not resolved"]},{"year":2005,"claim":"Showing that LEKTI and its kallikrein targets are co-stored in lamellar granules but in separate compartments, with LEKTI secreted ahead of KLK5/KLK7, explained how premature protease activation is prevented and why LEKTI absence causes suprabasal splitting.","evidence":"Immunoelectron microscopy and confocal microscopy of normal and NS epidermis","pmids":["15675955"],"confidence":"High","gaps":["Molecular basis of differential secretion timing unknown","Mechanism of compartment segregation within lamellar granules not defined"]},{"year":2005,"claim":"Domain-resolved kinetics revealed that LEKTI fragments containing domains 6–12 are potent, pH-sensitive inhibitors of KLK5 (Ki ~1–6 nM at pH 8, weaker at pH 5), establishing pH as the control switch for kallikrein release during desquamation.","evidence":"Recombinant LEKTI domain fragments tested against purified KLK5 and KLK7 with equilibrium and kinetic measurements at pH 8.0 and 5.0","pmids":["16307483","16307658"],"confidence":"High","gaps":["In vivo pH gradient across stratum corneum not directly correlated with fragment dissociation","Contribution of each individual domain not fully deconvolved"]},{"year":2006,"claim":"Correlating the magnitude of KLK5/KLK7 hyperactivity with barrier defect severity in NS patients, and showing downstream proteolysis of lipid-processing enzymes and corneodesmosomes, mapped the full pathogenic cascade from LEKTI loss to barrier failure.","evidence":"Protease activity assays, electron microscopy of lamellar membranes, DSG1/DSC1 western blotting in NS patient epidermis stratified by clinical severity","pmids":["16601670"],"confidence":"High","gaps":["Relative contributions of KLK5 vs. KLK7 vs. other proteases to each downstream effect not separated","Compensatory DSG3/DSC3 upregulation mechanism not defined"]},{"year":2007,"claim":"Comprehensive mapping of furin-generated LEKTI fragments and their differential KLK5/KLK7/KLK14 inhibitory profiles — identifying D8–D11 as the strongest KLK5 inhibitor forming an irreversible tight-binding complex released at acidic pH — provided the definitive biochemical framework for LEKTI-mediated protease regulation.","evidence":"Panel of LEKTI antibodies, kinetic analysis of all major fragments against KLK5, KLK7, KLK14 at multiple pH values","pmids":["17596512","17989726"],"confidence":"High","gaps":["Crystal structure of LEKTI–KLK complex not available","Contribution of in vivo co-factors or lipid environment not tested"]},{"year":2010,"claim":"Lentiviral SPINK5 rescue of NS keratinocytes restored normal epidermal architecture in organotypic and xenograft models, with bystander correction of surrounding cells, confirming that secreted LEKTI is both necessary and sufficient for barrier function.","evidence":"Lentiviral transduction of NS keratinocytes, organotypic culture, mouse xenograft engraftment","pmids":["20877344"],"confidence":"Medium","gaps":["Long-term durability of correction not assessed","Single lab study without independent replication"]},{"year":2011,"claim":"Mapping the complete proteolytic activation cascade of LEKTI in vivo, including three new processing intermediates, and showing that fragment-to-KLK5 ratios in the uppermost epidermis are compatible with fine-tuned inhibitory control refined the quantitative model of desquamation regulation.","evidence":"Antibody mapping, N-terminal sequencing, site-specific mutagenesis, quantitative fragment analysis in human epidermis","pmids":["21697885"],"confidence":"High","gaps":["Dynamic turnover rates of individual fragments in vivo unknown","Redundancy with other protease inhibitors not assessed"]},{"year":2012,"claim":"The common E420K polymorphism was shown to redirect furin cleavage within the D6–D7 linker, preventing formation of the D6–D9 fragment with peak KLK5-inhibitory activity, thereby linking a common SPINK5 variant to enhanced protease activity, DSG1 loss, and TSLP-driven inflammation.","evidence":"In vitro furin cleavage assays of wild-type vs. E420K LEKTI, in situ zymography, DSG1 and TSLP immunohistochemistry in 420KK patient epidermis","pmids":["22730493"],"confidence":"High","gaps":["Population-level impact on atopic dermatitis risk not mechanistically resolved in this study","Whether other processing enzymes compensate for altered furin cleavage unknown"]},{"year":2014,"claim":"Identifying mesotrypsin (PRSS3) as a protease that activates pro-KLK5/KLK7 and simultaneously degrades LEKTI inhibitory domains — while being resistant to LEKTI inhibition — positioned mesotrypsin as an upstream regulator of the LEKTI–KLK axis in desquamation.","evidence":"In vitro activation and degradation assays with recombinant mesotrypsin, proximity ligation assay in human skin sections","pmids":["24390132"],"confidence":"High","gaps":["In vivo genetic evidence for mesotrypsin's role (e.g. PRSS3 knockout) not available","Regulation of mesotrypsin activity itself not defined"]},{"year":2016,"claim":"Demonstrating compensatory LEKTI upregulation in atopic dermatitis lesions, correlating with retained corneodesmosomes and compact hyperkeratosis despite elevated KLK7 protein, revealed that LEKTI acts as a bidirectional rheostat — its deficiency causes over-desquamation while its excess causes under-desquamation.","evidence":"Western blot, immunostaining, electron microscopy, in situ zymography on AD patient tape-stripped corneocytes","pmids":["27769847"],"confidence":"Medium","gaps":["Mechanism driving LEKTI upregulation in AD not identified","Whether LEKTI excess is cause or consequence of compact hyperkeratosis not resolved"]},{"year":null,"claim":"Key open questions include: the structural basis of pH-dependent LEKTI–KLK complex dissociation (no crystal structure available); the in vivo hierarchy and redundancy among LEKTI fragments and other epidermal protease inhibitors; genetic validation of mesotrypsin's in vivo role upstream of LEKTI–KLK; and whether LEKTI's reported effects on Wnt/β-catenin and STAT3 signaling in cancer represent direct mechanisms or indirect consequences of protease regulation.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structural model of any LEKTI domain–KLK complex","In vivo genetic epistasis between PRSS3 and SPINK5 not tested","SPINK5-STAT3 interaction mechanism not established beyond indirect Co-IP"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,4,5,6,8,9]}],"localization":[{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[3]},{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[0,1,3]}],"pathway":[{"term_id":"R-HSA-1500931","term_label":"Cell-Cell communication","supporting_discovery_ids":[3,7,9]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[7,17,18]}],"complexes":[],"partners":["KLK5","KLK7","KLK14","FURIN","PRSS3","DSG1"],"other_free_text":[]},"mechanistic_narrative":"SPINK5 encodes LEKTI, a multi-domain serine protease inhibitor that is the master regulator of kallikrein-mediated desquamation in stratified epithelia. LEKTI is synthesized as a high-molecular-weight precursor in differentiated keratinocytes, rapidly cleaved by furin into multiple bioactive single- and multi-domain fragments that are stored in lamellar granules separately from their targets KLK5, KLK7, and KLK14, and secreted into the extracellular space of the stratum granulosum where they potently inhibit these kallikreins through tight-binding, pH-dependent interactions — with acidic pH triggering kallikrein release to permit corneodesmosomal proteolysis at the skin surface [PMID:17596512, PMID:16307483, PMID:15675955]. Loss-of-function mutations in SPINK5 cause Netherton syndrome, characterized by uncontrolled serine protease activity leading to premature corneodesmosome degradation, lipid processing enzyme proteolysis, lamellar membrane disorganization, and severe skin barrier failure [PMID:11874482, PMID:16601670]. The common E420K variant alters furin cleavage priorities, preventing formation of the most potent KLK5-inhibitory fragment (D6–D9) and resulting in enhanced protease activity, reduced desmoglein-1, and increased TSLP expression [PMID:22730493]. Mesotrypsin (PRSS3) functions upstream of LEKTI by both activating pro-KLK5/KLK7 and degrading LEKTI inhibitory domains, placing LEKTI within a multi-tiered proteolytic cascade controlling epidermal homeostasis [PMID:24390132]."},"prefetch_data":{"uniprot":{"accession":"Q9NQ38","full_name":"Serine protease inhibitor Kazal-type 5","aliases":["Lympho-epithelial Kazal-type-related inhibitor","LEKTI"],"length_aa":1064,"mass_kda":120.7,"function":"Serine protease inhibitor, probably important for the anti-inflammatory and/or antimicrobial protection of mucous epithelia. Contribute to the integrity and protective barrier function of the skin by regulating the activity of defense-activating and desquamation-involved proteases. Inhibits KLK5, its major target, in a pH-dependent manner. Inhibits KLK7, KLK14 CASP14, and trypsin","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/Q9NQ38/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SPINK5","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SPINK5","total_profiled":1310},"omim":[{"mim_id":"615868","title":"SERINE PEPTIDASE INHIBITOR, KAZAL-TYPE, 6; SPINK6","url":"https://www.omim.org/entry/615868"},{"mim_id":"615508","title":"ERYTHRODERMA, CONGENITAL, WITH PALMOPLANTAR KERATODERMA, HYPOTRICHOSIS, AND HYPER-IgE; EPKHE","url":"https://www.omim.org/entry/615508"},{"mim_id":"606797","title":"ST14 TRANSMEMBRANE SERINE PROTEASE MATRIPTASE; ST14","url":"https://www.omim.org/entry/606797"},{"mim_id":"605845","title":"DERMATITIS, ATOPIC, 6; ATOD6","url":"https://www.omim.org/entry/605845"},{"mim_id":"605010","title":"SERINE PROTEASE INHIBITOR, KAZAL-TYPE, 5; SPINK5","url":"https://www.omim.org/entry/605010"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Vesicles","reliability":"Enhanced"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"cervix","ntpm":538.7},{"tissue":"esophagus","ntpm":953.6},{"tissue":"lymphoid tissue","ntpm":274.6},{"tissue":"skin 1","ntpm":300.2},{"tissue":"vagina","ntpm":552.2}],"url":"https://www.proteinatlas.org/search/SPINK5"},"hgnc":{"alias_symbol":["VAKTI","LEKTI","LETKI","NETS","NS","FLJ21544","FLJ97536","FLJ97596","FLJ99794","DKFZp686K19184"],"prev_symbol":[]},"alphafold":{"accession":"Q9NQ38","domains":[{"cath_id":"3.30.60.30","chopping":"23-85","consensus_level":"medium","plddt":76.3868,"start":23,"end":85},{"cath_id":"3.30.60.30","chopping":"283-353","consensus_level":"medium","plddt":80.0031,"start":283,"end":353},{"cath_id":"3.30.60.30","chopping":"365-425","consensus_level":"medium","plddt":74.2392,"start":365,"end":425},{"cath_id":"3.30.60.30","chopping":"434-537","consensus_level":"high","plddt":81.2673,"start":434,"end":537},{"cath_id":"3.30.60.30","chopping":"782-820","consensus_level":"high","plddt":79.2895,"start":782,"end":820},{"cath_id":"3.30.60.30","chopping":"853-905","consensus_level":"medium","plddt":73.7217,"start":853,"end":905},{"cath_id":"3.30.60.30","chopping":"912-965","consensus_level":"high","plddt":78.9656,"start":912,"end":965},{"cath_id":"3.30.60.30","chopping":"995-1044","consensus_level":"high","plddt":87.3598,"start":995,"end":1044}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NQ38","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NQ38-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NQ38-F1-predicted_aligned_error_v6.png","plddt_mean":74.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SPINK5","jax_strain_url":"https://www.jax.org/strain/search?query=SPINK5"},"sequence":{"accession":"Q9NQ38","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9NQ38.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9NQ38/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NQ38"}},"corpus_meta":[{"pmid":"20471444","id":"PMC_20471444","title":"A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness.","date":"2010","source":"Progress in neuro-psychopharmacology & biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/20471444","citation_count":836,"is_preprint":false},{"pmid":"24366358","id":"PMC_24366358","title":"Thrombosis: tangled up in NETs.","date":"2013","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/24366358","citation_count":673,"is_preprint":false},{"pmid":"31736963","id":"PMC_31736963","title":"DAMPs and NETs in Sepsis.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31736963","citation_count":492,"is_preprint":false},{"pmid":"32740860","id":"PMC_32740860","title":"A Review of Neutrophil Extracellular Traps (NETs) in Disease: Potential Anti-NETs Therapeutics.","date":"2021","source":"Clinical reviews in allergy & immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32740860","citation_count":475,"is_preprint":false},{"pmid":"33042107","id":"PMC_33042107","title":"The Emerging Role of Neutrophil Extracellular Traps (NETs) in Tumor Progression and Metastasis.","date":"2020","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33042107","citation_count":428,"is_preprint":false},{"pmid":"9881847","id":"PMC_9881847","title":"Perineuronal nets: past and present.","date":"1998","source":"Trends in neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/9881847","citation_count":414,"is_preprint":false},{"pmid":"33431847","id":"PMC_33431847","title":"Perineuronal nets stabilize the grid cell network.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33431847","citation_count":295,"is_preprint":false},{"pmid":"19945487","id":"PMC_19945487","title":"Structure and functionality in flavivirus NS-proteins: perspectives for drug design.","date":"2009","source":"Antiviral research","url":"https://pubmed.ncbi.nlm.nih.gov/19945487","citation_count":255,"is_preprint":false},{"pmid":"17596512","id":"PMC_17596512","title":"LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction.","date":"2007","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/17596512","citation_count":237,"is_preprint":false},{"pmid":"32276504","id":"PMC_32276504","title":"Neutrophil Extracellular Traps (NETs) Take the Central Stage in Driving Autoimmune Responses.","date":"2020","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/32276504","citation_count":219,"is_preprint":false},{"pmid":"34503307","id":"PMC_34503307","title":"Neutrophil Extracellular Traps (NETs) in Cancer Invasion, Evasion and Metastasis.","date":"2021","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/34503307","citation_count":192,"is_preprint":false},{"pmid":"27446071","id":"PMC_27446071","title":"The Emerging Role of NETs in Venous Thrombosis and Immunothrombosis.","date":"2016","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27446071","citation_count":191,"is_preprint":false},{"pmid":"26432901","id":"PMC_26432901","title":"At the Bench: Neutrophil extracellular traps (NETs) highlight novel aspects of innate immune system involvement in autoimmune diseases.","date":"2015","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/26432901","citation_count":178,"is_preprint":false},{"pmid":"30398672","id":"PMC_30398672","title":"Insecticide-treated nets for preventing malaria.","date":"2018","source":"The Cochrane database of systematic reviews","url":"https://pubmed.ncbi.nlm.nih.gov/30398672","citation_count":166,"is_preprint":false},{"pmid":"32773102","id":"PMC_32773102","title":"Devilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression.","date":"2020","source":"Advances in biological regulation","url":"https://pubmed.ncbi.nlm.nih.gov/32773102","citation_count":166,"is_preprint":false},{"pmid":"18387844","id":"PMC_18387844","title":"New insights into transcriptional regulation by H-NS.","date":"2008","source":"Current opinion in microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/18387844","citation_count":166,"is_preprint":false},{"pmid":"23819131","id":"PMC_23819131","title":"Neutrophil extracellular traps (NETs) - formation and implications.","date":"2013","source":"Acta biochimica Polonica","url":"https://pubmed.ncbi.nlm.nih.gov/23819131","citation_count":165,"is_preprint":false},{"pmid":"8212562","id":"PMC_8212562","title":"The NS 3 nonstructural protein of flaviviruses contains an RNA triphosphatase activity.","date":"1993","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/8212562","citation_count":163,"is_preprint":false},{"pmid":"12915442","id":"PMC_12915442","title":"LEKTI proteolytic processing in human primary keratinocytes, tissue distribution and defective expression in Netherton syndrome.","date":"2003","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12915442","citation_count":162,"is_preprint":false},{"pmid":"11874482","id":"PMC_11874482","title":"Elevated stratum corneum hydrolytic activity in Netherton syndrome suggests an inhibitory regulation of desquamation by SPINK5-derived peptides.","date":"2002","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/11874482","citation_count":154,"is_preprint":false},{"pmid":"35032828","id":"PMC_35032828","title":"Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality.","date":"2022","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/35032828","citation_count":153,"is_preprint":false},{"pmid":"25938591","id":"PMC_25938591","title":"Simplified Human Neutrophil Extracellular Traps (NETs) Isolation and Handling.","date":"2015","source":"Journal of visualized experiments : JoVE","url":"https://pubmed.ncbi.nlm.nih.gov/25938591","citation_count":150,"is_preprint":false},{"pmid":"11841556","id":"PMC_11841556","title":"Netherton syndrome: disease expression and spectrum of SPINK5 mutations in 21 families.","date":"2002","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/11841556","citation_count":144,"is_preprint":false},{"pmid":"30629284","id":"PMC_30629284","title":"Untangling \"NETosis\" from NETs.","date":"2019","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30629284","citation_count":135,"is_preprint":false},{"pmid":"12752122","id":"PMC_12752122","title":"Association of SPINK5 gene polymorphisms with atopic dermatitis in the Japanese population.","date":"2003","source":"The British journal of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/12752122","citation_count":135,"is_preprint":false},{"pmid":"16601670","id":"PMC_16601670","title":"Serine protease activity and residual LEKTI expression determine phenotype in Netherton syndrome.","date":"2006","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/16601670","citation_count":134,"is_preprint":false},{"pmid":"30961634","id":"PMC_30961634","title":"Neutrophil extracellular traps (NETs) exacerbate severity of infant sepsis.","date":"2019","source":"Critical care (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/30961634","citation_count":120,"is_preprint":false},{"pmid":"31428515","id":"PMC_31428515","title":"DNA released from neutrophil extracellular traps (NETs) activates pancreatic stellate cells and enhances pancreatic tumor growth.","date":"2019","source":"Oncoimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/31428515","citation_count":117,"is_preprint":false},{"pmid":"15675955","id":"PMC_15675955","title":"LEKTI is localized in lamellar granules, separated from KLK5 and KLK7, and is secreted in the extracellular spaces of the superficial stratum granulosum.","date":"2005","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/15675955","citation_count":116,"is_preprint":false},{"pmid":"7748941","id":"PMC_7748941","title":"The chromatin-associated protein H-NS.","date":"1994","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/7748941","citation_count":106,"is_preprint":false},{"pmid":"26927887","id":"PMC_26927887","title":"Social amoebae trap and kill bacteria by casting DNA nets.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/26927887","citation_count":104,"is_preprint":false},{"pmid":"36902325","id":"PMC_36902325","title":"Molecular Mechanisms of Neutrophil Extracellular Trap (NETs) Degradation.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36902325","citation_count":102,"is_preprint":false},{"pmid":"10844682","id":"PMC_10844682","title":"Oligomerization of the chromatin-structuring protein H-NS.","date":"2000","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/10844682","citation_count":102,"is_preprint":false},{"pmid":"2137660","id":"PMC_2137660","title":"NS-1 and NS-2 proteins may act synergistically in the cytopathogenicity of parvovirus MVMp.","date":"1990","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/2137660","citation_count":96,"is_preprint":false},{"pmid":"14551605","id":"PMC_14551605","title":"Association between polymorphisms in the SPINK5 gene and atopic dermatitis in the Japanese.","date":"2003","source":"Genes and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/14551605","citation_count":95,"is_preprint":false},{"pmid":"16307658","id":"PMC_16307658","title":"hK5 and hK7, two serine proteinases abundant in human skin, are inhibited by LEKTI domain 6.","date":"2005","source":"The British journal of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/16307658","citation_count":94,"is_preprint":false},{"pmid":"29703474","id":"PMC_29703474","title":"Platelets, NETs and cancer.","date":"2018","source":"Thrombosis research","url":"https://pubmed.ncbi.nlm.nih.gov/29703474","citation_count":89,"is_preprint":false},{"pmid":"27913665","id":"PMC_27913665","title":"Structure and function of bacterial H-NS protein.","date":"2016","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/27913665","citation_count":87,"is_preprint":false},{"pmid":"1010155","id":"PMC_1010155","title":"Morphogenesis of lines and nets.","date":"1976","source":"Differentiation; research in biological diversity","url":"https://pubmed.ncbi.nlm.nih.gov/1010155","citation_count":86,"is_preprint":false},{"pmid":"25375226","id":"PMC_25375226","title":"Silencing by H-NS potentiated the evolution of Salmonella.","date":"2014","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/25375226","citation_count":79,"is_preprint":false},{"pmid":"16307483","id":"PMC_16307483","title":"Inhibition of human kallikreins 5 and 7 by the serine protease inhibitor lympho-epithelial Kazal-type inhibitor (LEKTI).","date":"2005","source":"Biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16307483","citation_count":76,"is_preprint":false},{"pmid":"12667078","id":"PMC_12667078","title":"Inhibition of serine proteinases plasmin, trypsin, subtilisin A, cathepsin G, and elastase by LEKTI: a kinetic analysis.","date":"2003","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12667078","citation_count":76,"is_preprint":false},{"pmid":"22730493","id":"PMC_22730493","title":"The 420K LEKTI variant alters LEKTI proteolytic activation and results in protease deregulation: implications for atopic dermatitis.","date":"2012","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22730493","citation_count":75,"is_preprint":false},{"pmid":"33466589","id":"PMC_33466589","title":"Significance of NETs Formation in COVID-19.","date":"2021","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/33466589","citation_count":74,"is_preprint":false},{"pmid":"34445556","id":"PMC_34445556","title":"Neutrophil Extracellular Traps (NETs) in Severe SARS-CoV-2 Lung Disease.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34445556","citation_count":74,"is_preprint":false},{"pmid":"31443560","id":"PMC_31443560","title":"Perineuronal Nets and Their Role in Synaptic Homeostasis.","date":"2019","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31443560","citation_count":72,"is_preprint":false},{"pmid":"17989726","id":"PMC_17989726","title":"Correlation between SPINK5 gene mutations and clinical manifestations in Netherton syndrome patients.","date":"2007","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/17989726","citation_count":71,"is_preprint":false},{"pmid":"28428948","id":"PMC_28428948","title":"Understanding the Entanglement: Neutrophil Extracellular Traps (NETs) in Cystic Fibrosis.","date":"2017","source":"Frontiers in cellular and infection microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/28428948","citation_count":70,"is_preprint":false},{"pmid":"34885240","id":"PMC_34885240","title":"Neutrophil Extracellular Traps (NETs) in Cancer Metastasis.","date":"2021","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/34885240","citation_count":67,"is_preprint":false},{"pmid":"35854322","id":"PMC_35854322","title":"The potential roles of type I interferon activated neutrophils and neutrophil extracellular traps (NETs) in the pathogenesis of primary Sjögren's syndrome.","date":"2022","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/35854322","citation_count":64,"is_preprint":false},{"pmid":"21697885","id":"PMC_21697885","title":"Proteolytic activation cascade of the Netherton syndrome-defective protein, LEKTI, in the epidermis: implications for skin homeostasis.","date":"2011","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/21697885","citation_count":60,"is_preprint":false},{"pmid":"25638302","id":"PMC_25638302","title":"H-NS and RNA polymerase: a love-hate relationship?","date":"2015","source":"Current opinion in microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/25638302","citation_count":59,"is_preprint":false},{"pmid":"27614687","id":"PMC_27614687","title":"NETs in cancer.","date":"2016","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27614687","citation_count":59,"is_preprint":false},{"pmid":"33670641","id":"PMC_33670641","title":"A Look into Bunyavirales Genomes: Functions of Non-Structural (NS) Proteins.","date":"2021","source":"Viruses","url":"https://pubmed.ncbi.nlm.nih.gov/33670641","citation_count":56,"is_preprint":false},{"pmid":"18774391","id":"PMC_18774391","title":"Analysis of the individual and aggregate genetic contributions of previously identified serine peptidase inhibitor Kazal type 5 (SPINK5), kallikrein-related peptidase 7 (KLK7), and filaggrin (FLG) polymorphisms to eczema risk.","date":"2008","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/18774391","citation_count":55,"is_preprint":false},{"pmid":"20877344","id":"PMC_20877344","title":"Ex-vivo gene therapy restores LEKTI activity and corrects the architecture of Netherton syndrome-derived skin grafts.","date":"2010","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/20877344","citation_count":53,"is_preprint":false},{"pmid":"20048772","id":"PMC_20048772","title":"Diverse functions of perineuronal nets.","date":"2009","source":"Acta neurobiologiae experimentalis","url":"https://pubmed.ncbi.nlm.nih.gov/20048772","citation_count":52,"is_preprint":false},{"pmid":"30597093","id":"PMC_30597093","title":"H-NS uses an autoinhibitory conformational switch for environment-controlled gene silencing.","date":"2019","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/30597093","citation_count":52,"is_preprint":false},{"pmid":"38189504","id":"PMC_38189504","title":"Neutrophil extracellular traps (NETs) in cardiovascular diseases: From molecular mechanisms to therapeutic interventions.","date":"2023","source":"Kardiologia polska","url":"https://pubmed.ncbi.nlm.nih.gov/38189504","citation_count":51,"is_preprint":false},{"pmid":"32845378","id":"PMC_32845378","title":"NETs in APS: Current Knowledge and Future Perspectives.","date":"2020","source":"Current rheumatology reports","url":"https://pubmed.ncbi.nlm.nih.gov/32845378","citation_count":51,"is_preprint":false},{"pmid":"23021640","id":"PMC_23021640","title":"Neutrophil extracellular traps (NETs) and infection-related vascular dysfunction.","date":"2012","source":"Blood reviews","url":"https://pubmed.ncbi.nlm.nih.gov/23021640","citation_count":50,"is_preprint":false},{"pmid":"20168283","id":"PMC_20168283","title":"Imaging of NETs with PET radiopharmaceuticals.","date":"2010","source":"The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...","url":"https://pubmed.ncbi.nlm.nih.gov/20168283","citation_count":49,"is_preprint":false},{"pmid":"31729003","id":"PMC_31729003","title":"Detection, Visualization, and Quantification of Neutrophil Extracellular Traps (NETs) and NET Markers.","date":"2020","source":"Methods in molecular biology (Clifton, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/31729003","citation_count":48,"is_preprint":false},{"pmid":"39020018","id":"PMC_39020018","title":"Astrocytes require perineuronal nets to maintain synaptic homeostasis in mice.","date":"2024","source":"Nature neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/39020018","citation_count":47,"is_preprint":false},{"pmid":"31572386","id":"PMC_31572386","title":"Aggregated NETs Sequester and Detoxify Extracellular Histones.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31572386","citation_count":44,"is_preprint":false},{"pmid":"24390132","id":"PMC_24390132","title":"Keratinocyte-specific mesotrypsin contributes to the desquamation process via kallikrein activation and LEKTI degradation.","date":"2014","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/24390132","citation_count":44,"is_preprint":false},{"pmid":"35561448","id":"PMC_35561448","title":"Association between neutrophil extracellular traps (NETs) and thrombosis in antiphospholipid syndrome.","date":"2022","source":"Thrombosis research","url":"https://pubmed.ncbi.nlm.nih.gov/35561448","citation_count":43,"is_preprint":false},{"pmid":"21585560","id":"PMC_21585560","title":"Association of SPINK5 gene polymorphisms with atopic dermatitis in Northeast China.","date":"2011","source":"Journal of the European Academy of Dermatology and Venereology : JEADV","url":"https://pubmed.ncbi.nlm.nih.gov/21585560","citation_count":43,"is_preprint":false},{"pmid":"35538389","id":"PMC_35538389","title":"Radiomics in pulmonary neuroendocrine tumours (NETs).","date":"2022","source":"La Radiologia medica","url":"https://pubmed.ncbi.nlm.nih.gov/35538389","citation_count":42,"is_preprint":false},{"pmid":"34194670","id":"PMC_34194670","title":"Staphylococcus aureus induces neutrophil extracellular traps (NETs) and neutralizes their bactericidal potential.","date":"2021","source":"Computational and structural biotechnology journal","url":"https://pubmed.ncbi.nlm.nih.gov/34194670","citation_count":42,"is_preprint":false},{"pmid":"30868765","id":"PMC_30868765","title":"A novel tumor suppressor SPINK5 targets Wnt/β-catenin signaling pathway in esophageal cancer.","date":"2019","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30868765","citation_count":40,"is_preprint":false},{"pmid":"26904301","id":"PMC_26904301","title":"Caught in the Net: Perineuronal Nets and Addiction.","date":"2016","source":"Neural plasticity","url":"https://pubmed.ncbi.nlm.nih.gov/26904301","citation_count":40,"is_preprint":false},{"pmid":"15507732","id":"PMC_15507732","title":"Three-periodic nets and tilings: minimal nets.","date":"2004","source":"Acta crystallographica. Section A, Foundations of crystallography","url":"https://pubmed.ncbi.nlm.nih.gov/15507732","citation_count":39,"is_preprint":false},{"pmid":"33577121","id":"PMC_33577121","title":"Innate Immune Cells and Hypertension: Neutrophils and Neutrophil Extracellular Traps (NETs).","date":"2021","source":"Comprehensive Physiology","url":"https://pubmed.ncbi.nlm.nih.gov/33577121","citation_count":38,"is_preprint":false},{"pmid":"8655567","id":"PMC_8655567","title":"H-NS regulates OmpF expression through micF antisense RNA in Escherichia coli.","date":"1996","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/8655567","citation_count":38,"is_preprint":false},{"pmid":"27769847","id":"PMC_27769847","title":"Incomplete KLK7 Secretion and Upregulated LEKTI Expression Underlie Hyperkeratotic Stratum Corneum in Atopic Dermatitis.","date":"2016","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/27769847","citation_count":36,"is_preprint":false},{"pmid":"35920993","id":"PMC_35920993","title":"Aging hampers neutrophil extracellular traps (NETs) efficacy.","date":"2022","source":"Aging clinical and experimental research","url":"https://pubmed.ncbi.nlm.nih.gov/35920993","citation_count":34,"is_preprint":false},{"pmid":"34484432","id":"PMC_34484432","title":"Current treatments and future potential of surufatinib in neuroendocrine tumors (NETs).","date":"2021","source":"Therapeutic advances in medical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/34484432","citation_count":34,"is_preprint":false},{"pmid":"25415587","id":"PMC_25415587","title":"Exploring the interaction of N/S compounds with a dicopper center: tyrosinase inhibition and model studies.","date":"2014","source":"Inorganic chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25415587","citation_count":34,"is_preprint":false},{"pmid":"15753894","id":"PMC_15753894","title":"Polymorphisms in SPINK5 are not associated with asthma in a Dutch population.","date":"2005","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/15753894","citation_count":34,"is_preprint":false},{"pmid":"16374478","id":"PMC_16374478","title":"SPINK5, the defective gene in netherton syndrome, encodes multiple LEKTI isoforms derived from alternative pre-mRNA processing.","date":"2006","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/16374478","citation_count":31,"is_preprint":false},{"pmid":"36942262","id":"PMC_36942262","title":"The Formation of NETs and Their Mechanism of Promoting Tumor Metastasis.","date":"2023","source":"Journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/36942262","citation_count":30,"is_preprint":false},{"pmid":"38555028","id":"PMC_38555028","title":"Low-Density Neutrophils and Neutrophil Extracellular Traps (NETs) Are New Inflammatory Players in Heart Failure.","date":"2024","source":"The Canadian journal of cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/38555028","citation_count":29,"is_preprint":false},{"pmid":"24825365","id":"PMC_24825365","title":"Differentially instructive extracellular protein micro-nets.","date":"2014","source":"Journal of the American Chemical Society","url":"https://pubmed.ncbi.nlm.nih.gov/24825365","citation_count":29,"is_preprint":false},{"pmid":"24390486","id":"PMC_24390486","title":"Gastrointestinal neuroendocrine tumors (NETs): new diagnostic and therapeutic challenges.","date":"2014","source":"Cancer metastasis reviews","url":"https://pubmed.ncbi.nlm.nih.gov/24390486","citation_count":28,"is_preprint":false},{"pmid":"17140555","id":"PMC_17140555","title":"Proteolytic processing of human growth hormone by multiple tissue kallikreins and regulation by the serine protease inhibitor Kazal-Type5 (SPINK5) protein.","date":"2006","source":"Clinica chimica acta; international journal of clinical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17140555","citation_count":27,"is_preprint":false},{"pmid":"38490994","id":"PMC_38490994","title":"TGF-β-driven LIF expression influences neutrophil extracellular traps (NETs) and contributes to peritoneal metastasis in gastric cancer.","date":"2024","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/38490994","citation_count":26,"is_preprint":false},{"pmid":"22524286","id":"PMC_22524286","title":"Knotting the NETs: analyzing histone modifications in neutrophil extracellular traps.","date":"2012","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/22524286","citation_count":26,"is_preprint":false},{"pmid":"39384116","id":"PMC_39384116","title":"S100A7 orchestrates neutrophil chemotaxis and drives neutrophil extracellular traps (NETs) formation to facilitate lymph node metastasis in cervical cancer patients.","date":"2024","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/39384116","citation_count":25,"is_preprint":false},{"pmid":"35441845","id":"PMC_35441845","title":"Nets, pulmonary arterial hypertension, and thrombo-inflammation.","date":"2022","source":"Journal of molecular medicine (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/35441845","citation_count":25,"is_preprint":false},{"pmid":"11891144","id":"PMC_11891144","title":"The 15-domain serine proteinase inhibitor LEKTI: biochemical properties, genomic organization, and pathophysiological role.","date":"2002","source":"European journal of medical research","url":"https://pubmed.ncbi.nlm.nih.gov/11891144","citation_count":25,"is_preprint":false},{"pmid":"22924981","id":"PMC_22924981","title":"Gene silencing by H-NS from distal DNA site.","date":"2012","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/22924981","citation_count":25,"is_preprint":false},{"pmid":"40102634","id":"PMC_40102634","title":"Neutrophils and NETs in kidney disease.","date":"2025","source":"Nature reviews. Nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/40102634","citation_count":24,"is_preprint":false},{"pmid":"37781373","id":"PMC_37781373","title":"The involvement of NETs in ANCA-associated vasculitis.","date":"2023","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37781373","citation_count":24,"is_preprint":false},{"pmid":"33192123","id":"PMC_33192123","title":"Compound K improves skin barrier function by increasing SPINK5 expression.","date":"2019","source":"Journal of ginseng research","url":"https://pubmed.ncbi.nlm.nih.gov/33192123","citation_count":24,"is_preprint":false},{"pmid":"35705923","id":"PMC_35705923","title":"Metformin inhibits melanoma cell metastasis by suppressing the miR-5100/SPINK5/STAT3 axis.","date":"2022","source":"Cellular & molecular biology letters","url":"https://pubmed.ncbi.nlm.nih.gov/35705923","citation_count":23,"is_preprint":false},{"pmid":"29424946","id":"PMC_29424946","title":"Interference of transcription across H-NS binding sites and repression by H-NS.","date":"2018","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/29424946","citation_count":23,"is_preprint":false},{"pmid":"39164300","id":"PMC_39164300","title":"H-NS is a bacterial transposon capture protein.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/39164300","citation_count":22,"is_preprint":false},{"pmid":"38906006","id":"PMC_38906006","title":"Nets in fibrosis: Bridging innate immunity and tissue remodeling.","date":"2024","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/38906006","citation_count":22,"is_preprint":false},{"pmid":"36359815","id":"PMC_36359815","title":"Correlation between Neutrophil Extracellular Traps (NETs) Expression and Primary Graft Dysfunction Following Human Lung Transplantation.","date":"2022","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/36359815","citation_count":22,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":45988,"output_tokens":5281,"usd":0.10859},"stage2":{"model":"claude-opus-4-6","input_tokens":8779,"output_tokens":3218,"usd":0.186518},"total_usd":0.295108,"stage1_batch_id":"msgbatch_011rkcQdVV1RaFq9XhcG6df6","stage2_batch_id":"msgbatch_01RzgrJafdF4EWHhj5mNi6dh","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2007,\n      \"finding\": \"LEKTI is produced as a precursor rapidly cleaved by furin, generating multiple single or multidomain fragments (D1, D5, D6, D8-D11, D9-D15) that are secreted in keratinocytes and epidermis. All LEKTI fragments except D1 specifically and differentially inhibit human kallikreins 5, 7, and 14, with the strongest inhibition by D8-D11 toward KLK5 in a rapid, irreversible, tight-binding complex. pH governs this interaction, with acidic pH releasing active KLK5 from the complex, enabling precisely regulated KLK5 activity and corneodesmosomal cleavage in the superficial stratum corneum.\",\n      \"method\": \"Biochemical analysis with panel of LEKTI antibodies, kinetic analysis of inhibitory activity on serine proteases, pH-dependent interaction assays\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro kinetic assay with multiple orthogonal methods, strong mechanistic dissection of pH-dependent regulation\",\n      \"pmids\": [\"17596512\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"LEKTI is expressed as a 145 kDa full-length protein and a 125 kDa isoform in differentiated keratinocytes; both are N-glycosylated and rapidly processed in a post-endoplasmic reticulum compartment into C-terminal fragments of 42, 65, and 68 kDa by furin. Treatment with a furin inhibitor blocked processing, and in vitro cleavage of recombinant 145 kDa precursor by furin generated the 65 and 68 kDa C-terminal fragments directly.\",\n      \"method\": \"Monoclonal/polyclonal antibody detection, furin inhibitor treatment of keratinocytes, in vitro cleavage assay with recombinant furin, conditioned media analysis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro cleavage plus cell-based inhibitor experiments with multiple orthogonal methods\",\n      \"pmids\": [\"12915442\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Loss-of-function SPINK5 mutations cause markedly elevated trypsin-like hydrolytic activity in stratum corneum of Netherton syndrome patients, supporting the model that SPINK5-derived LEKTI peptides normally inhibit serine proteases to regulate corneocyte desquamation.\",\n      \"method\": \"SPINK5 mutation characterization, enzymatic activity assay of trypsin-like hydrolytic activity in stratum corneum from NS patients vs. controls\",\n      \"journal\": \"The Journal of investigative dermatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with specific biochemical readout, single lab\",\n      \"pmids\": [\"11874482\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"LEKTI and its kallikrein targets KLK5 and KLK7 are all localized within lamellar granules of normal epidermis but are separately stored; LEKTI is secreted earlier than KLK7 and KLK5, preventing premature loss of stratum corneum integrity. In Netherton syndrome skin lacking LEKTI, an abnormal split in the superficial stratum granulosum is observed.\",\n      \"method\": \"Confocal laser scanning microscopy and immunoelectron microscopy of human epidermis; comparison with NS patient skin\",\n      \"journal\": \"The Journal of investigative dermatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct subcellular localization by immunoelectron microscopy with functional consequence in disease model, replicated with NS patient tissue\",\n      \"pmids\": [\"15675955\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"LEKTI domain 6 is a potent inhibitor of hK5 (KLK5) and hK7 (KLK7) at nanomolar concentrations, while LEKTI domain 15 inhibits plasmin. This identifies KLK5 and KLK7 as specific physiological targets of LEKTI domain 6 relevant to skin desquamation and inflammation.\",\n      \"method\": \"In vitro inhibitory activity assays of recombinant LEKTI domains 6 and 15 against purified kallikreins hK5 and hK7\",\n      \"journal\": \"The British journal of dermatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro biochemical assay with purified recombinant proteins, domain-specific functional mapping\",\n      \"pmids\": [\"16307658\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"LEKTI fragments containing Kazal domains 6-8 and 9-12 potently inhibit recombinant KLK5 (Ki 1.2–5.5 nM at pH 8.0; 10–20 nM at pH 5.0) with slow dissociation rates (t1/2 ~20–25 min), indicating tight and specific binding. Only fragment 6-9' was a good inhibitor of KLK7 (Ki 11 nM at pH 8.0), with rapidly reversible kinetics. Lower pH reduces inhibitory potency, consistent with a pH-controlled release mechanism.\",\n      \"method\": \"Recombinant protein expression, kinetic and equilibrium binding studies measuring Ki, kass, and kdis at pH 8.0 and 5.0\",\n      \"journal\": \"Biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstituted kinetic assay with rigorous quantitation at multiple pH values\",\n      \"pmids\": [\"16307483\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Full-length recombinant LEKTI (rLEKTI) inhibits serine proteinases plasmin, subtilisin A, cathepsin G, human neutrophil elastase, and trypsin via a noncompetitive mechanism (Ki values: 27 nM for plasmin to 849 nM for trypsin), but does not inhibit chymotrypsin or cysteine proteinases. Disulfide bonds are required for inhibitory activity.\",\n      \"method\": \"Baculovirus/insect cell recombinant expression, kinetic inhibition assays, DTT inactivation experiments\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstituted assay with multiple substrates and mechanism determination\",\n      \"pmids\": [\"12667078\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"The magnitude of serine protease (KLK5, KLK7) activation in the stratum corneum correlates with permeability barrier defect severity and clinical severity in Netherton syndrome, and inversely with residual LEKTI expression. LEKTI co-localizes with KLK5 and KLK7 in the stratum corneum and inhibits both. Excess serine protease activity in NS leads to proteolysis of lipid hydrolases (beta-glucocerebrosidase, acidic sphingomyelinase), disorganization of lamellar membranes, and degradation of corneodesmosomes via DSG1/DSC1 cleavage, with compensatory upregulation of DSG3/DSC3.\",\n      \"method\": \"Patient phenotype correlation with SP activity assays, LEKTI immunolocalization, lamellar membrane analysis by electron microscopy, desmoglein/desmocollin western blotting\",\n      \"journal\": \"The Journal of investigative dermatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods in patient tissue establishing mechanistic pathway from LEKTI loss to barrier phenotype\",\n      \"pmids\": [\"16601670\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"LEKTI domain specificity for inhibiting SC protease activities was mapped: domains 6-12 predominantly inhibit trypsin-like (Phe-Ser-Arg-) activity; domains 12-15 inhibit plasmin- and trypsin-like (Pro-Phe-Arg-) activities; all domains inhibit chymotrypsin-like activity; no domains inhibit furin-like activity. KLK levels are significantly elevated in the SC and serum of NS patients, and LEKTI domain length correlates with protease inhibitory activity and clinical severity.\",\n      \"method\": \"Recombinant LEKTI domain proteins, protease inhibition assays with SC extracts, KLK quantification by immunoassay in NS patients\",\n      \"journal\": \"The Journal of investigative dermatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — domain-specific inhibitory mapping with recombinant proteins correlated with patient genotype/phenotype\",\n      \"pmids\": [\"17989726\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"A proteolytic activation cascade of LEKTI in the epidermis was defined by antibody mapping, N-terminal sequencing, and site-specific mutagenesis, identifying most physiologically generated LEKTI polypeptides and three new processing intermediates. The most effective LEKTI fragments against desquamation-related KLKs were shown to inhibit KLK-mediated proteolysis of desmoglein-1, and fragment ratios relative to active KLK5 in the uppermost epidermis are compatible with fine-tuned inhibitory control.\",\n      \"method\": \"Antibody mapping, N-terminal sequencing, site-specific mutagenesis, KLK proteolysis assays, fragment quantification in epidermis\",\n      \"journal\": \"The Journal of investigative dermatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution with mutagenesis plus mass spectrometric sequencing and quantitative fragment analysis\",\n      \"pmids\": [\"21697885\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The common LEKTI E420K variant (Glu420Lys) increases furin-dependent cleavage within the D6-D7 linker region, reversing cleavage priorities during LEKTI activation and preventing formation of the D6-D9 fragment with the strongest KLK5-inhibitory activity. This results in enhanced KLK5, KLK7, and elastase-2 activities in 420KK epidermis, reduced DSG1 expression, accelerated profilaggrin proteolysis, and increased TSLP expression.\",\n      \"method\": \"In vitro furin cleavage assays, in situ and gel zymographies, immunohistochemistry, western blot in patient-derived 420KK epidermis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — biochemical reconstitution of cleavage plus multiple orthogonal functional readouts in patient tissue\",\n      \"pmids\": [\"22730493\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"SPINK5 generates three classes of transcripts by alternative pre-mRNA processing, encoding three LEKTI isoforms differing in their C-terminal portion (15-domain, 13-domain, and a longer isoform with a 30-amino-acid insertion between domains 13 and 14). All isoforms are translated in differentiated keratinocytes and generate distinct secreted C-terminal proteolytic fragments from a similar cleavage site.\",\n      \"method\": \"RT-PCR, protein expression analysis in differentiated keratinocytes, N-terminal sequencing of secreted fragments\",\n      \"journal\": \"The Journal of investigative dermatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — alternative splicing characterization with protein-level validation in keratinocytes\",\n      \"pmids\": [\"16374478\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Lentiviral SPINK5 gene delivery to NS keratinocytes restored LEKTI expression in previously deficient cells. Genetically corrected NS keratinocytes formed normal epidermal architecture in organotypic culture and in vivo mouse/human skin grafts, including a bystander benefit in surrounding uncorrected cells, consistent with LEKTI being a secreted protein.\",\n      \"method\": \"Lentiviral transduction of NS keratinocytes, organotypic culture, in vivo xenograft engraftment model, immunofluorescence for LEKTI and epidermal markers\",\n      \"journal\": \"Molecular therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function rescue with defined functional and architectural readouts in two model systems\",\n      \"pmids\": [\"20877344\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Keratinocyte-specific mesotrypsin (PRSS3) activates pro-KLK5 and pro-KLK7 in vitro, and degrades LEKTI inhibitory domains (D2, D2-5, D2-6, D2-7, D5, D6, D6-9, D7, D7-9, D10-15) that normally suppress KLK activity—whereas mesotrypsin itself is not inhibited by these LEKTI fragments. Proximity ligation assay demonstrated close association between mesotrypsin and KLKs in granular to cornified layers, placing mesotrypsin upstream of KLK activation and LEKTI degradation in desquamation.\",\n      \"method\": \"In vitro activation assays of KLK zymogens by mesotrypsin, LEKTI domain inhibition/degradation assays, immunoelectron microscopy, proximity ligation assay in human skin sections\",\n      \"journal\": \"The Journal of investigative dermatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro reconstitution plus in situ proximity ligation providing pathway position for LEKTI regulation\",\n      \"pmids\": [\"24390132\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"LEKTI and KLK5, KLK6, and KLK14 are expressed in the pituitary gland. SPINK5 inhibitory domain fragments suppress KLK4, KLK5, and KLK14 activities in vitro. KLKs 4-6, 8, 13, and 14 cleave human growth hormone (hGH) in vitro, generating isoforms, suggesting SPINK5/LEKTI regulates KLK-mediated hGH processing in the pituitary.\",\n      \"method\": \"RT-PCR and immunohistochemistry for expression in pituitary, in vitro recombinant hGH digestion by KLKs, N-terminal sequencing of fragments, LEKTI fragment inhibition of KLK activities\",\n      \"journal\": \"Clinica chimica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution but in a non-skin tissue context with single lab\",\n      \"pmids\": [\"17140555\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SPINK5 overexpression in esophageal cancer cells inhibits the Wnt/β-catenin signaling pathway by inhibiting GSK3β phosphorylation and promoting β-catenin protein degradation (shown in combination with LiCl or MG-132 treatment). SPINK5 overexpression in vivo significantly inhibits esophageal cancer cell growth. Co-immunoprecipitation confirmed an indirect interaction between SPINK5 (LEKTI) and STAT3.\",\n      \"method\": \"Western blot for Wnt/β-catenin components, LiCl/MG-132 chemical epistasis, in vivo tumor growth assay, Co-IP for SPINK5-STAT3 interaction\",\n      \"journal\": \"Cancer medicine\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, indirect Co-IP and chemical epistasis without direct enzymatic mechanism established\",\n      \"pmids\": [\"30868765\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"miR-5100 targets SPINK5 mRNA (confirmed by luciferase reporter assay), reducing LEKTI expression and thereby activating STAT3 phosphorylation, promoting melanoma cell metastasis via epithelial-mesenchymal transition. Metformin inhibits the miR-5100/SPINK5/STAT3 pathway. Co-IP confirmed an indirect interaction between SPINK5 and STAT3.\",\n      \"method\": \"Luciferase reporter assay for miR-5100 targeting SPINK5, migration/wound healing assays, Co-IP, in vivo metastasis model in mice\",\n      \"journal\": \"Cellular & molecular biology letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — luciferase validation of miRNA targeting plus functional assays, but SPINK5-STAT3 mechanism is indirect\",\n      \"pmids\": [\"35705923\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Compound K (CK), an active ginsenoside metabolite, increases SPINK5 gene promoter activity and SPINK5/LEKTI expression in UVB-irradiated keratinocytes, resulting in decreased downstream KLK5, KLK7, and PAR2 expression, and restored epidermal barrier function (transepidermal water loss, hydration) in UVB-irradiated and DNCB-induced atopic dermatitis mouse models.\",\n      \"method\": \"Transactivation (promoter) assay, RT-PCR, western blot in HaCaT cells, TEWL and hydration measurement, histology in mouse models\",\n      \"journal\": \"Journal of ginseng research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — promoter activity assay with in vivo functional readouts, mechanistic pathway positioned through SPINK5 induction\",\n      \"pmids\": [\"33192123\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"In atopic dermatitis lesions, KLK7 secretion from lamellar granules is impaired and LEKTI expression is increased, correlating with retention of corneodesmosomes and compact hyperkeratosis. In situ zymography showed that KLK activity on tape-stripped corneocytes from AD lesions was not significantly elevated despite increased KLK7 protein levels, implicating upregulated LEKTI as a compensatory mechanism suppressing desquamation.\",\n      \"method\": \"Western blot, immunostaining, electron microscopy, in situ zymography on AD patient tape-stripped corneocytes\",\n      \"journal\": \"The Journal of investigative dermatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods in patient tissue linking LEKTI upregulation to impaired protease activity and clinical phenotype\",\n      \"pmids\": [\"27769847\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SPINK5 encodes LEKTI, a multi-domain serine protease inhibitor that is synthesized as a high-molecular-weight precursor in differentiated keratinocytes, cleaved by furin into multiple bioactive fragments stored separately from its targets KLK5 and KLK7 in lamellar granules, secreted into the extracellular space of the stratum granulosum, and there potently inhibits KLK5, KLK7, and KLK14 in a pH-dependent manner—releasing active kallikreins at acidic pH to enable precisely regulated corneodesmosomal proteolysis and desquamation, with loss of LEKTI function causing uncontrolled serine protease activity, barrier breakdown, and Netherton syndrome.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"SPINK5 encodes LEKTI, a multi-domain serine protease inhibitor that is the master regulator of kallikrein-mediated desquamation in stratified epithelia. LEKTI is synthesized as a high-molecular-weight precursor in differentiated keratinocytes, rapidly cleaved by furin into multiple bioactive single- and multi-domain fragments that are stored in lamellar granules separately from their targets KLK5, KLK7, and KLK14, and secreted into the extracellular space of the stratum granulosum where they potently inhibit these kallikreins through tight-binding, pH-dependent interactions — with acidic pH triggering kallikrein release to permit corneodesmosomal proteolysis at the skin surface [PMID:17596512, PMID:16307483, PMID:15675955]. Loss-of-function mutations in SPINK5 cause Netherton syndrome, characterized by uncontrolled serine protease activity leading to premature corneodesmosome degradation, lipid processing enzyme proteolysis, lamellar membrane disorganization, and severe skin barrier failure [PMID:11874482, PMID:16601670]. The common E420K variant alters furin cleavage priorities, preventing formation of the most potent KLK5-inhibitory fragment (D6–D9) and resulting in enhanced protease activity, reduced desmoglein-1, and increased TSLP expression [PMID:22730493]. Mesotrypsin (PRSS3) functions upstream of LEKTI by both activating pro-KLK5/KLK7 and degrading LEKTI inhibitory domains, placing LEKTI within a multi-tiered proteolytic cascade controlling epidermal homeostasis [PMID:24390132].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"Establishing that SPINK5 loss of function leads to excess serine protease activity in the stratum corneum linked the gene product to direct protease inhibition during desquamation and confirmed its role in Netherton syndrome pathogenesis.\",\n      \"evidence\": \"Enzymatic activity assays of trypsin-like activity in stratum corneum of NS patients with characterized SPINK5 mutations versus controls\",\n      \"pmids\": [\"11874482\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab, no identification of specific protease targets\", \"Mechanism of inhibition not determined\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Defining furin as the processing protease and mapping LEKTI precursor cleavage into discrete C-terminal fragments established the biosynthetic pathway from full-length precursor to secreted inhibitory peptides.\",\n      \"evidence\": \"Furin inhibitor treatment of keratinocytes blocked processing; in vitro cleavage of recombinant 145 kDa precursor by purified furin reconstituted the fragments\",\n      \"pmids\": [\"12915442\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Exact number and identity of all physiological fragments not yet known\", \"N-terminal fragments not characterized\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Demonstrating that full-length recombinant LEKTI inhibits multiple serine proteinases (plasmin, subtilisin A, cathepsin G, elastase, trypsin) via a noncompetitive mechanism requiring disulfide bonds established the biochemical class of inhibition.\",\n      \"evidence\": \"Kinetic inhibition assays with baculovirus-expressed LEKTI against a panel of serine and cysteine proteinases, with DTT inactivation\",\n      \"pmids\": [\"12667078\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological kallikrein targets (KLK5, KLK7) not yet tested\", \"Domain-specific contributions not resolved\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Showing that LEKTI and its kallikrein targets are co-stored in lamellar granules but in separate compartments, with LEKTI secreted ahead of KLK5/KLK7, explained how premature protease activation is prevented and why LEKTI absence causes suprabasal splitting.\",\n      \"evidence\": \"Immunoelectron microscopy and confocal microscopy of normal and NS epidermis\",\n      \"pmids\": [\"15675955\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of differential secretion timing unknown\", \"Mechanism of compartment segregation within lamellar granules not defined\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Domain-resolved kinetics revealed that LEKTI fragments containing domains 6–12 are potent, pH-sensitive inhibitors of KLK5 (Ki ~1–6 nM at pH 8, weaker at pH 5), establishing pH as the control switch for kallikrein release during desquamation.\",\n      \"evidence\": \"Recombinant LEKTI domain fragments tested against purified KLK5 and KLK7 with equilibrium and kinetic measurements at pH 8.0 and 5.0\",\n      \"pmids\": [\"16307483\", \"16307658\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo pH gradient across stratum corneum not directly correlated with fragment dissociation\", \"Contribution of each individual domain not fully deconvolved\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Correlating the magnitude of KLK5/KLK7 hyperactivity with barrier defect severity in NS patients, and showing downstream proteolysis of lipid-processing enzymes and corneodesmosomes, mapped the full pathogenic cascade from LEKTI loss to barrier failure.\",\n      \"evidence\": \"Protease activity assays, electron microscopy of lamellar membranes, DSG1/DSC1 western blotting in NS patient epidermis stratified by clinical severity\",\n      \"pmids\": [\"16601670\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contributions of KLK5 vs. KLK7 vs. other proteases to each downstream effect not separated\", \"Compensatory DSG3/DSC3 upregulation mechanism not defined\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Comprehensive mapping of furin-generated LEKTI fragments and their differential KLK5/KLK7/KLK14 inhibitory profiles — identifying D8–D11 as the strongest KLK5 inhibitor forming an irreversible tight-binding complex released at acidic pH — provided the definitive biochemical framework for LEKTI-mediated protease regulation.\",\n      \"evidence\": \"Panel of LEKTI antibodies, kinetic analysis of all major fragments against KLK5, KLK7, KLK14 at multiple pH values\",\n      \"pmids\": [\"17596512\", \"17989726\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Crystal structure of LEKTI–KLK complex not available\", \"Contribution of in vivo co-factors or lipid environment not tested\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Lentiviral SPINK5 rescue of NS keratinocytes restored normal epidermal architecture in organotypic and xenograft models, with bystander correction of surrounding cells, confirming that secreted LEKTI is both necessary and sufficient for barrier function.\",\n      \"evidence\": \"Lentiviral transduction of NS keratinocytes, organotypic culture, mouse xenograft engraftment\",\n      \"pmids\": [\"20877344\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Long-term durability of correction not assessed\", \"Single lab study without independent replication\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Mapping the complete proteolytic activation cascade of LEKTI in vivo, including three new processing intermediates, and showing that fragment-to-KLK5 ratios in the uppermost epidermis are compatible with fine-tuned inhibitory control refined the quantitative model of desquamation regulation.\",\n      \"evidence\": \"Antibody mapping, N-terminal sequencing, site-specific mutagenesis, quantitative fragment analysis in human epidermis\",\n      \"pmids\": [\"21697885\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Dynamic turnover rates of individual fragments in vivo unknown\", \"Redundancy with other protease inhibitors not assessed\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"The common E420K polymorphism was shown to redirect furin cleavage within the D6–D7 linker, preventing formation of the D6–D9 fragment with peak KLK5-inhibitory activity, thereby linking a common SPINK5 variant to enhanced protease activity, DSG1 loss, and TSLP-driven inflammation.\",\n      \"evidence\": \"In vitro furin cleavage assays of wild-type vs. E420K LEKTI, in situ zymography, DSG1 and TSLP immunohistochemistry in 420KK patient epidermis\",\n      \"pmids\": [\"22730493\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Population-level impact on atopic dermatitis risk not mechanistically resolved in this study\", \"Whether other processing enzymes compensate for altered furin cleavage unknown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identifying mesotrypsin (PRSS3) as a protease that activates pro-KLK5/KLK7 and simultaneously degrades LEKTI inhibitory domains — while being resistant to LEKTI inhibition — positioned mesotrypsin as an upstream regulator of the LEKTI–KLK axis in desquamation.\",\n      \"evidence\": \"In vitro activation and degradation assays with recombinant mesotrypsin, proximity ligation assay in human skin sections\",\n      \"pmids\": [\"24390132\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo genetic evidence for mesotrypsin's role (e.g. PRSS3 knockout) not available\", \"Regulation of mesotrypsin activity itself not defined\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Demonstrating compensatory LEKTI upregulation in atopic dermatitis lesions, correlating with retained corneodesmosomes and compact hyperkeratosis despite elevated KLK7 protein, revealed that LEKTI acts as a bidirectional rheostat — its deficiency causes over-desquamation while its excess causes under-desquamation.\",\n      \"evidence\": \"Western blot, immunostaining, electron microscopy, in situ zymography on AD patient tape-stripped corneocytes\",\n      \"pmids\": [\"27769847\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism driving LEKTI upregulation in AD not identified\", \"Whether LEKTI excess is cause or consequence of compact hyperkeratosis not resolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key open questions include: the structural basis of pH-dependent LEKTI–KLK complex dissociation (no crystal structure available); the in vivo hierarchy and redundancy among LEKTI fragments and other epidermal protease inhibitors; genetic validation of mesotrypsin's in vivo role upstream of LEKTI–KLK; and whether LEKTI's reported effects on Wnt/β-catenin and STAT3 signaling in cancer represent direct mechanisms or indirect consequences of protease regulation.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structural model of any LEKTI domain–KLK complex\", \"In vivo genetic epistasis between PRSS3 and SPINK5 not tested\", \"SPINK5-STAT3 interaction mechanism not established beyond indirect Co-IP\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 4, 5, 6, 8, 9]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [0, 1, 3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1500931\", \"supporting_discovery_ids\": [3, 7, 9]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [7, 17, 18]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"KLK5\",\n      \"KLK7\",\n      \"KLK14\",\n      \"FURIN\",\n      \"PRSS3\",\n      \"DSG1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}